EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CDH1 loss remodels gene expression and lineage identity in human mammary epithelial cells

Maggie Musick iD, Chinasa A Ufondu iD, Carmen E Rowland, Micaela E Brown, Joseph L Sottnik iD, Madeleine T Shackleford, Camryn S Nesiba, Etienne P Danis iD, Andrew E Goodspeed, Richard Zera, Arthur T Johnson, Kathryn L Schwertfeger und 3 weitere

PLOS Genetics · 27.10.2026 · 22 (10) · e1012351

DOI: 10.1371/journal.pgen.1012351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 27.10.2026. Verfasst von Maggie Musick und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Colorado Anschutz, Aurora, Colorado, United States of America. Hauptthemen laut MEDLINE: Cadherins, Epithelial Cells, Antigens, CD, Mammary Glands, Human. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, U.S. Department of Defense, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive lobular carcinoma (ILC) is a common subtype of breast cancer, molecularly defined by genetic loss of CDH1, and subsequent loss of cell adhesion protein E-cadherin, in ~95% of ILC. Though CDH1 loss occurs early in ILC oncogenesis, it is unclear how this facilitates transformation. We modeled early CDH1 loss using “normal” human mammary epithelial cells (HMEC), i.e., finite lifespan cells reflecting early hyperplasia, and targeted E-cadherin signaling using antibodies versus causing genetic CDH1 loss using siRNA or CRISPR/Cas9-knockout. Transcriptome analysis across four HMEC models showed that the mode of E-cadherin targeting is critical for the subsequent phenotype. Antibody-mediated inhibition of cell-cell contacts induced gene signatures of epithelial-mesenchymal transition (EMT), consistent with the role of E-cadherin suppression during the EMT process. Conversely, genetic CDH1 loss – as in ILC oncogenesis – repressed EMT signatures, and instead remodeled gene expression toward a luminal epithelial phenotype. RNA-seq, single cell transcriptomics, flow cytometry, microscopy, and ATAC-seq analyses support that CDH1 loss induces lineage remodeling to a luminal state, which is mirrored in transcriptomic analysis of clinical ILC precursor lesions. By isolating luminal versus basal cells prior to CDH1 knockout, we found that CDH1 loss led to remodeling of lineage identity in both populations, converging on a new lineage homeostasis with a luminal progenitor-like phenotype. Consistent with the shift to a luminal progenitor phenotype, CDH1 loss enhanced proliferative capacity over the finite lifespan of the HMECs, highlighting a feature of early CDH1 loss that may contribute to clonal advantage during tumor initiation. Moreover, CDH1 loss enhanced anoikis resistance, a defining feature of ILC cells. Our findings support that genetic loss of CDH1 in mammary epithelial cells induces transcriptional and phenotypic changes consistent with lineage identity remodeling toward a luminal progenitor-like state, which may underpin the mechanism by which early CDH1 loss mediates ILC oncogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CadherinsEpithelial CellsAntigens, CDMammary Glands, HumanBreast NeoplasmsCarcinoma, LobularHumansFemaleEpithelial-Mesenchymal TransitionCell LineageGene Expression Regulation, NeoplasticCell Transformation, Neoplastic

Substanzen

CadherinsAntigens, CDCDH1 protein, human

Autor:innen und Institutionen

  • Department of Pathology, University of Colorado Anschutz, Aurora, Colorado, United States of America.
  • Department of Pharmacology, Molecular Pharmacology and Therapeutics (MPaT) Program, University of Minnesota, Twin Cities, Minneapolis, Minnesota, United States of America.
  • University of Colorado Cancer Center, University of Colorado Anschutz, Aurora, Colorado, United States of America.
  • Department of Biomedical Informatics, University of Colorado Anschutz, Aurora, Colorado, United States of America.
  • Hennepin County Medical Center, Minneapolis, Minnesota, United States of America.
  • Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, United States of America.

ORCID-Profile: Maggie Musick, Chinasa A Ufondu, Joseph L Sottnik, Etienne P Danis, Andrew C Nelson, Julie H Ostrander, Matthew J Sikora

Förderung

  • NCI NIH HHS
  • U.S. Department of Defense
  • American Cancer Society
  • Lobular Breast Cancer Research Fund at CU Anschutz
  • National Institutes of Health
  • National Cancer Institute (NCI), National Institutes of Health

Zitieren

APA

Musick, M., Ufondu, C. A., Rowland, C. E., Brown, M. E., Sottnik, J. L., Shackleford, M. T., Nesiba, C. S., Danis, E. P., Goodspeed, A. E., Zera, R., Johnson, A. T., Schwertfeger, K. L., Nelson, A. C., Ostrander, J. H., & Sikora, M. J. (2026). CDH1 loss remodels gene expression and lineage identity in human mammary epithelial cells. PLOS Genetics, 22(10), e1012351. https://doi.org/10.1371/journal.pgen.1012351

Vancouver

Musick M, Ufondu CA, Rowland CE, Brown ME, Sottnik JL, Shackleford MT, et al. CDH1 loss remodels gene expression and lineage identity in human mammary epithelial cells. PLOS Genetics. 2026;22(10):e1012351. doi:10.1371/journal.pgen.1012351

BibTeX
@article{Musick2026,
  author = {Musick, Maggie and Ufondu, Chinasa A and Rowland, Carmen E and Brown, Micaela E and Sottnik, Joseph L and Shackleford, Madeleine T and Nesiba, Camryn S and Danis, Etienne P and Goodspeed, Andrew E and Zera, Richard and Johnson, Arthur T and Schwertfeger, Kathryn L and Nelson, Andrew C and Ostrander, Julie H and Sikora, Matthew J},
  title = {CDH1 loss remodels gene expression and lineage identity in human mammary epithelial cells},
  journal = {PLOS Genetics},
  year = {2026},
  volume = {22},
  number = {10},
  pages = {e1012351},
  doi = {10.1371/journal.pgen.1012351}
}
Kostenlos starten →